Cargando…
Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter]
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657740/ https://www.ncbi.nlm.nih.gov/pubmed/38026611 http://dx.doi.org/10.2147/OPTH.S447229 |
_version_ | 1785148198862454784 |
---|---|
author | Shah, Shalin Goel, Ruchi |
author_facet | Shah, Shalin Goel, Ruchi |
author_sort | Shah, Shalin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10657740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106577402023-11-15 Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter] Shah, Shalin Goel, Ruchi Clin Ophthalmol Letter Dove 2023-11-15 /pmc/articles/PMC10657740/ /pubmed/38026611 http://dx.doi.org/10.2147/OPTH.S447229 Text en © 2023 Shah and Goel. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Letter Shah, Shalin Goel, Ruchi Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter] |
title | Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter] |
title_full | Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter] |
title_fullStr | Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter] |
title_full_unstemmed | Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter] |
title_short | Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter] |
title_sort | epiphora in treated lacrimal drainage system malignancy patients – when and whom to treat? [letter] |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657740/ https://www.ncbi.nlm.nih.gov/pubmed/38026611 http://dx.doi.org/10.2147/OPTH.S447229 |
work_keys_str_mv | AT shahshalin epiphoraintreatedlacrimaldrainagesystemmalignancypatientswhenandwhomtotreatletter AT goelruchi epiphoraintreatedlacrimaldrainagesystemmalignancypatientswhenandwhomtotreatletter |